Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Thursday, July 17, 2014

iPad Technology for Home Rehabilitation after Stroke (iHOME): A proof-of-concept randomized trial

Don't you know enough to search for existing research on your topic of choice? My god are these people obtuse.
Like this:

Constant Therapy Launches iPad Solution for People with Traumatic Brain Injury, Stroke, Aphasia and Learning Disabilities

Multineurons is developing head-worn sensor & iPad app to monitor patients with brain disorders

Constant Therapy rolls out mobile, personalized brain rehabilitation via the iPad

Prototyping a Tablet Application for the Rehabilitation of Stroke Patients

23 others for the iPad 

 

 

 



http://onlinelibrary.wiley.com/doi/10.1111/ijs.12328/abstract;jsessionid=4F8A0565DD11A287C580BDD72D31C7C1.f04t01?
  1. Gustavo Saposnik1,2,*,
  2. Chi-Ming Chow3,
  3. David Gladstone4,
  4. Donna Cheung1,
  5. Edward Brawer3,
  6. Kevin E. Thorpe5,
  7. Avon Saldanha6,
  8. Alice Dang6,
  9. Mark Bayley7,
  10. Tom A. Schweizer2 and
  11. on behalf of the iHOME Research Team for the Stroke Outcomes Research Canada Working Group†
Article first published online: 7 JUL 2014
DOI: 10.1111/ijs.12328
Additional Information(Show All)
  1. Conflict of interest: None declared.
  2. Clinicaltrials.gov registration: NCT01836159
  3. Funding: This study is supported by the Ontario Stroke Network, funded by the Ontario Ministry of Health and Long-Term Care, and by the Canadian Partnership for Stroke Recovery, funded by the Heart and Stroke Foundation of Canada. No support is received from Apple. Dr Saposnik is supported by the Heart and Stroke Foundation of Canada (HSFC) Distinguished Clinician Scientist Award. Dr Schweizer is supported by the HSFC New Investigator Award.
  4. Principal investigators: Dr Saposnik and Dr Chow are the co-PIs of iHOME Acute. Dr Saposnik, Dr Gladstone, and Dr Schweizer are the co-PIs of iHOME Chronic. Dr Bayley is the site PI at Toronto Rehabilitation.



More Sharing ServicesShare|Share on citeulikeShare on facebookShare on deliciousShare on www.mendeley.comShare on twitter
View Full Article (HTML) Enhanced Article (HTML) Get PDF (409K)

Keywords:

  • outcomes;
  • rehabilitation;
  • stroke;
  • tablet technology

Background

Tablets are a novel line of computers controlled by a multitouch screen. Fine motor movements are captured on the tablet computer through electrical fields and can be qualitatively and quantitatively assessed. Evidence is limited on tablet use for stroke rehabilitation.

Methods

iHOME is an investigator-initiated randomized controlled pilot trial with a single-blinded outcome assessment. The intervention consists of iPad use (investigational group) vs. usual care (control group) among patients receiving conventional outpatient rehabilitation. Eligibility includes aged 18–85 years who experienced a mild ischemic or hemorrhagic stroke (as diagnosed on neuroimaging and determined by the Chedoke–McMaster score ≥3. The STROKE REHAB® software for the iPad was specifically designed for patients with fine motor weakness and/or neglect. Of the total 30 patients, 20 will be in iHOME Acute (enrolled within three-months of stroke onset) and 10 patients in iHOME Chronic (enrolled more than six-months from onset).

Outcome measures

The primary feasibility outcome is the proportion of the scheduled iPad time used (more than 70% (≥140 mins) of the total ‘dose’ of intervention intended will be considered successful). Efficacy in fine motor movements will be assessed using the nine-hole peg test; time to magnify and pop the balloons in the iPad software application, and improvement in Wolf Motor Function Test.

Conclusions

iHOME is a randomized controlled trial assessing the feasibility, safety, and efficacy of tablet technology for home use in stroke rehabilitation. The results of this study will serve as the basis for a larger multicenter trial.
Posted by at
Labels: , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)